MYCN and neuroblastoma: While ceRNA interactions can be easily detected and validated in extreme cases—as in MYCN-amplified neuroblastomas [16] or binding-site rich RNAs [15], our results suggest that they affect the expression of thousands of genes and have the potential to synergistically dysregulate drivers of tumorigenesis in multiple tumor contexts.